Identification |
Name: | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)- |
Synonyms: | 4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;9-Dimethylaminomethyl-10-hydroxycamptothecin;(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; |
CAS: | 123948-87-8 |
EINECS: | 231-595-7 |
Molecular Formula: | C23H23N3O5 |
Molecular Weight: | 421.45 |
InChI: | InChI=1/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1 |
Molecular Structure: |
|
Properties |
Transport: | UN 3286 3/PG 2 |
Density: | 1.49g/cm3 |
Refractive index: | 1.733 |
Solubility: | soluble in water |
Appearance: | light yellow needle crystal or crystalline powder |
Packinggroup: | II |
Safety Data |
Hazard Symbols |
|
|
|